Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$8.14M Hold
151,638
0.58% 43
2017
Q3
$9.27M Sell
151,638
-14,098
-9% -$855K 0.6% 38
2017
Q2
$10.1M Sell
165,736
-19,264
-10% -$1.17M 0.62% 34
2017
Q1
$11.2M Sell
185,000
-9,904
-5% -$601K 0.62% 33
2016
Q4
$10.9M Sell
194,904
-32,387
-14% -$1.9M 0.76% 31
2016
Q3
$13.5M Buy
227,291
+92,047
+68% +$5.38M 0.97% 17
2016
Q2
$7.43M Sell
135,244
-31,276
-19% -$1.66M 0.56% 52
2016
Q1
$8.41M Sell
166,520
-24,966
-13% -$1.22M 0.53% 53
2015
Q4
$9.65M Sell
191,486
-46,004
-19% -$2.32M 0.57% 43
2015
Q3
$11.2M Sell
237,490
-429
-0.2% -$22.8K 0.28% 91
2015
Q2
$12.9M Sell
237,919
-915
-0.4% -$51.3K 0.28% 99
2015
Q1
$13.1M Buy
238,834
+1,949
+0.8% +$110K 0.37% 71
2014
Q4
$12.8M Hold
236,885
0.38% 79
2014
Q3
$13.4M Sell
236,885
-2,794
-1% -$157K 0.36% 83
2014
Q2
$13.2M Sell
239,679
-479
-0.2% -$26.1K 0.39% 67
2014
Q1
$13M Buy
+240,158
New +$12.4M 0.44% 61

Other funds holding MRK

GLG LLC's MRK Position: Q4 2017 in Review

GLG LLC held its Merck (MRK) position steady in Q4 2017 at 151,638 shares worth $8.14M. The position accounts for 0.58% of the portfolio, ranked #43.

GLG LLC first reported a position in MRK in Q1 2014 and has held it in 16 quarters since. The position peaked at $13.5M in Q3 2016. 2,009 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • GLG LLC held 151,638 shares of Merck worth $8.14M as of Q4 2017.
  • GLG LLC left its Merck share count unchanged in Q4 2017.
  • Merck made up 0.58% of GLG LLC's portfolio in Q4 2017, its #43 holding.
  • GLG LLC first reported a position in Merck in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Merck position peaked at $13.5M in Q3 2016.
  • 2,009 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.